reference/8662136

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8662136

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	5
issn	0392-856X
issueIdentifier	3
pageRange	500-5
publicationName	Clinical and experimental rheumatology
startingPage	500
bibliographicCitation	Mustila A, Korpela M, Haapala AM, Kautiainen H, Laasonen L, Möttönen T, Leirisalo-Repo M, Ilonen J, Järvenpää S, Luukkainen R, Hannonen P. Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies. Clin Exp Rheumatol. 2011 May;29(3):500–5. PMID: 21640044.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13767678cf760d12f93a4e7e6b943928 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1477cd0bfce7b1cfaac180939f4561f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47210c3a9902051ee6620d376a10fcff http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f918b61d6788365b5a5c0750135ced4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c99e29328ee44218ba614c9de938250 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96aa35899e3a7bc38e3cb5a725db4513 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffdcc9c7a78093c4c43d46539c08fcd1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d92553d968e9d28390cf89344d584009 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db6f6e318b1bae13ffbf5e7ef2232875 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3b156bd81f18509c7a8318b5bc66a274 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06a1ab5304fab022de28c5db865ac992
date	201105
identifier	https://pubmed.ncbi.nlm.nih.gov/21640044
isPartOf	https://portal.issn.org/resource/ISSN/0392-856X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3036
language	English
source	https://pubmed.ncbi.nlm.nih.gov/
title	Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies
discusses	http://id.nlm.nih.gov/mesh/M0016239 http://id.nlm.nih.gov/mesh/M0001324 http://id.nlm.nih.gov/mesh/M0027742 http://id.nlm.nih.gov/mesh/M0010751 http://id.nlm.nih.gov/mesh/M0013595 http://id.nlm.nih.gov/mesh/M0019365 http://id.nlm.nih.gov/mesh/M0017460 http://id.nlm.nih.gov/mesh/M0469115
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D018450 http://id.nlm.nih.gov/mesh/D018501Q000627 http://id.nlm.nih.gov/mesh/D000888Q000097 http://id.nlm.nih.gov/mesh/D011239Q000627 http://id.nlm.nih.gov/mesh/D010456Q000276 http://id.nlm.nih.gov/mesh/D001172Q000276 http://id.nlm.nih.gov/mesh/D001172Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D033023Q000000981 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D008727Q000627 http://id.nlm.nih.gov/mesh/D001172Q000000981 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D050823Q000000981 http://id.nlm.nih.gov/mesh/D006886Q000627 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D011859 http://id.nlm.nih.gov/mesh/D012460Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311007 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6852147 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9109 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5339 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_08107456d8bcd45da877127a55a55980 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e375a99a7c8f66894912f4770b9c5a76 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3652

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129756062 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128681276

Total number of triples: 69.